Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Laboratory grams consumed and peak breath alcohol concentration were co-primary outcomes
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the treatment of type 2 diabetes mellitus and, more recently, obesity
The only downside is increased stinging at the injection site
Kurki MI, Karjalainen J, Palta P, Sipil TP, Kristiansson K, Donner KM, et al
Be sure to let your healthcare provider know about any other medications you may be taking and any other medical conditions you have before starting or continuing the use of Ozempic
GLP-1 Market Key Players AstraZeneca Boehringer Ingelheim D&D Pharmatech Eli Lilly Hanmi Pharmaceutical Novo Nordisk Pfizer Roche Sanofi Tonghua Dongbao Pharmaceutical GLP-1 Pipeline Phases The GLP-1 agonists industry is evolving with key players advancing candidates through clinical stages for obesity, diabetes, and cardiometabolic indications
